Frank Czauderna Selected Research

peposertib

1/2022	DNA-PK Inhibitor Peposertib Amplifies Radiation-Induced Inflammatory Micronucleation and Enhances TGFβ/PD-L1 Targeted Cancer Immunotherapy.
12/2019	Therapeutic Implications of p53 Status on Cancer Cell Fate Following Exposure to Ionizing Radiation and the DNA-PK Inhibitor M3814.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frank Czauderna Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 06/2002
1	Bites and Stings (Sting) 01/2022
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2019
1	Prostatic Neoplasms (Prostate Cancer) 11/2003

Drug/Important Bio-Agent (IBA)

2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2022 - 12/2019
2	peposertibIBA 01/2022 - 12/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2019
2	Small Interfering RNA (siRNA)IBA 08/2004 - 11/2003
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 11/2003 - 06/2002
1	DNA-Activated Protein KinaseIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Monocarboxylic Acid TransportersIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	A-Form DNA (A-DNA)IBA 12/2019
1	Checkpoint Kinase 2IBA 12/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 06/2002
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 06/2002

Therapy/Procedure

2	Radiotherapy 01/2022 - 12/2019
1	Immunotherapy 01/2022
1	Therapeutics 01/2022
1	Radioimmunotherapy 01/2022